DNA topoisomerase II inhibitors.  [electronic resource] 

 -  IARC monographs on the evaluation of carcinogenic risks to humans  2000 
 - 175-344 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1017-1606 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amsacrine--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Carcinogens--adverse effects<br/>Disease Models, Animal<br/>Etoposide--adverse effects<br/>Evidence-Based Medicine<br/>Humans<br/>Intestinal Absorption<br/>Mitoxantrone--adverse effects<br/>Neoplasms--chemically induced<br/>Nucleic Acid Synthesis Inhibitors--adverse effects<br/>Research Design<br/>Risk Factors<br/>Teniposide--adverse effects<br/>Tissue Distribution<br/>Topoisomerase II Inhibitors